System and methods for combined harvest and capture of a biologic

US2025027032A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2025027032-A1
Application numberUS-202418775747-A
CountryUS
Kind codeA1
Filing dateJul 17, 2024
Priority dateJul 18, 2023
Publication dateJan 23, 2025
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides tangential flow filtration systems and methods for capture and harvest of a biologic product, and related compositions.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method for isolating a biologic product from a process fluid characterized by high cell density and/or high turbidity, comprising performing a capture operation by contacting the process fluid with a capture resin in a retentate fluid circuit of a filtration module for a period of time sufficient to allow binding of the biologic product to the resin; performing a wash operation by separating the process fluid and resin mixture into permeate and retentate fluid streams of the filtration module and recirculating the retentate fluid stream through the retentate fluid circuit for a first number of diafiltration volumes (DVs) while directing the permeate stream to a waste container outside the fluid circuit, thereby producing a clarified retentate fluid, and optionally concentrating the clarified retentate fluid in the retentate fluid circuit; performing an elution operation by contacting the clarified retentate fluid with a volume of elution buffer in the retentate fluid circuit for a period of time sufficient to allow disassociation of the biologic product from the resin; performing a harvest operation by circulating the clarified retentate fluid and resin mixture through the filtration module, thereby separating the mixture into a permeate fluid stream comprising the biologic product and a retentate stream comprising the resin; and recirculating the retentate fluid stream through the retentate fluid circuit for a second number of DVs while directing the permeate stream to a recovery container outside the fluid circuit, thereby isolating the biologic product in the recovery container. 2 . The method of claim 1 , wherein during one or both of the wash and harvest operations, fluid lost to the permeate stream is replaced to maintain a constant volume of fluid in the process vessel and/or the secondary vessel in either a batch or continuous process. 3 . The method of claim 1 , wherein during one or both of the wash and harvest operations, fluid lost to the permeate stream is not replaced in order to concentrate the fluid in the process vessel. 4 . The method of claim 1 , wherein the process fluid is characterized by a viable cell density (VCD) or total cell density (TCD) of from 10E5 to 10E9 cells/ml for insect or mammalian cells, or by an optical density (OD) of from 1-350 at 600 or 620 nanometers (nm) for bacterial cells. 5 . The method of claim 1 , wherein the process fluid is characterized by a turbidity of from 100-30,000 nephelometric turbidity units (NTUs) or from 200-1,000 NTU before contacting with the resin. 6 . The method of claim 1 , wherein the process fluid is characterized by a viscosity of from about 1.5-30 centipoise (cP). 7 . The method of claim 1 , wherein the wash operation is sufficient to remove 95-99% of cells and/or cellular proteins and nucleic acids from the retentate fluid stream. 8 . The method of claim 1 , wherein the wash operation is sufficient to achieve a 2-5 average log reduction of cellular proteins and nucleic acids in the retentate fluid stream. 9 . The method of claim 1 , wherein following the harvest operation, at least 90% of the resin is retained in the retentate fluid. 10 . The method of claim 1 , wherein following the harvest operation, the harvested biologic product is subjected to filtration through a tangential flow depth filtration (TFDF) filter medium. 11 . The method of claim 1 , wherein the filtration module comprises a tangential flow depth filtration (TFDF) filter medium comprising one or a plurality of hollow fiber elements forming a hollow fiber depth filter medium, each hollow fiber element consisting of a porous wall having a thickness of from 2-10 millimeters (mm) defining a lumen having an internal diameter (ID) of from 1-12 mm, a porosity of from about 50-90%, and a pore rating of from 10-50 microns. 12 . The method of claim 11 , wherein each of the one or a plurality of hollow fiber elements forming the hollow fiber depth filter medium consists of a porous wall having a thickness of from 2-10 mm defining a lumen having an ID of from 1-12 mm, a porosity of from about 60-90%, and a pore rating of 10, 20, 30, 40, or 50 microns. 13 . The method of claim 1 , wherein the filtration module comprises a large porosity tangential flow filtration (TFF) filter medium constructed of nonwoven fibers having pore size in the range of 50-200 microns. 14 . The method of claim 13 , wherein the filter medium is constructed from a nonwoven polypropylene/polyethylene polymer, a polyester polymer, a polyamide polymer, or a fluoropolymer. 15 . The method of claim 14 , wherein the filter medium includes a porous wall having a thickness of from 0.1 to 0.5 mm defining a lumen having an ID of from 1-12 mm and a porosity of from about 60-90%. 16 . The method of claim 15 , wherein the filter medium in the form of a flat sheet spiral wound into a tubular form, optionally thermally or ultrasonically welded to itself in a spiral pattern to form a tubular filter element. 17 . The method of claim 16 , wherein the filter medium is manufactured using wetlaid technology. 18 . The method of claim 17 , wherein the filter medium is not formed by extrusion. 19 . The method of claim 1 , wherein the biologic product is an antibody, a recombinant protein or a virus particle. 20 . The method of claim 19 wherein the resin is functionalized with Fc-binding ligands or ligands that bind to virus particles. 21 . A tangential flow filtration (TFF) module comprising a filter medium of a nonwoven polypropylene/polyethylene polymer in the form of a flat sheet spiral wound into a tubular form and having a pore size of from 50-200 microns, a porous wall having a thickness of from 0.1 to 0.5 mm defining a lumen having an internal diameter (ID) of from 1-12 millimeters, a porosity of from about 60-90%, and a pore rating of 40, 50, 100, 150, or 200 microns, and a housing adapted to separate a process fluid into permeate and retentate fluid streams as it flows through the filter medium, the housing provided with an inlet, a permeate outlet and a retentate outlet. 22 . A system for isolating a biologic product from a process fluid characterized by high cell density and/or high turbidity, comprising a process vessel containing the process fluid, at least one tangential flow filtration (TFF) module in fluid communication with the process vessel, the filtration module comprising a filter medium of a nonwoven polypropylene/polyethylene polymer in the form of a flat sheet spiral wound into a tubular form and having a pore size of from 50-200 microns, a porous wall having a thickness of from 0.1 to 0.5 mm defining a lumen having an internal diameter (ID) of from 1-12 millimeters, a porosity of from about 60-90%, and a pore rating of 40, 50, 100, 150, or 200 microns, and a housing adapted to separate a process fluid into permeate and retentate fluid streams as it flows through the filter medium, the housing provided with an inlet, a permeate outlet and a retentate outlet, a recirculation loop comprising flexible tubing interconnected between the process vessel and the TFF module to form a retentate fluid circuit, and at least one pump. 23 . The system of claim 22 , wherein at least two TFF modules are connected in series or in parallel with the process vessel, optionally wherein two or more units comprising a filtration module and process vessel are connected in series or in parallel.

Assignees

Inventors

Classifications

  • C12M47/04Primary

    Cell isolation or sorting (purging biological preparations of unwanted cells C12N5/0081, determining the presence or kind of microorganism C12Q1/04) · CPC title

  • by filtration, ultrafiltration or reverse osmosis · CPC title

  • Ion-exchange chromatography · CPC title

  • by a combination of two or more processes of different types · CPC title

  • C12M47/10Primary

    Separation or concentration of fermentation products (bioreactors combined with means for distillation or extraction of liquid fuel C12M43/02) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2025027032A1 cover?
The invention provides tangential flow filtration systems and methods for capture and harvest of a biologic product, and related compositions.
Who is the assignee on this patent?
Repligen Corp
What technology area does this patent fall under?
Primary CPC classification C12M47/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jan 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).